Skip to main content

Axcella's new long COVID medication helps some patients in small trial

Clinical trials of a new drug aimed at tackling symptoms of long COVID, made by Axcella, show that the drug worked in helping some patients overcome their fatigue.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.